Dr. Stanley Schwartz talks about addressing the epidemic of not only diabetes but the growing numbers of prediabetes patients. He reviews the current policy situation and then talks about how he proceeds in his practice with prediabetes patients.  He points out that several studies have shown that adding certain medications …

  Dr. Stanley Schwartz addresses the question of, “Where do we go from here?” regarding the beta-cell centric approach. He notes that there are two ways to approach the question — grassroots and a top-down approach — and says that both avenues should be pursued. He hopes that his his …

In this second set of Homerun Slides focusing on Type 1 Diabetes and Psychoeducation, we review the emotions that both children and parents may experience after an initial diagnosis and some of the challenges that both face in managing a child’s type 1 diabetes… To download the complete set of …

I was reviewing a client’s insulin administration. She was administering Levemir (insulin detemir), 60 units, with a FlexPen. She said that she just dialed the dose to the maximum it would allow her as she knew it only would dial to 60 units. She did not confirm the dose visually. Although …

Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Diabetic ketoacidosis (DKA) is a state of severe uncontrolled diabetes caused by insulin deficiency. It is characterised by hyperglycaemia, hyperketonaemia and metabolic acidosis, and has been somewhat arbitrarily divided into mild, moderate and severe based upon biochemical and clinical features (Table 12.1)….

FDA Approves New Once-Weekly GLP-1  See this week’s Item #1.

Trulicity™ (dulaglutide) Trulicity (dulaglutide) is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) just approved by the FDA that offers adults with type 2 diabetes once-weekly dosing in the Trulicity pen, which has a pre-attached, hidden needle and requires no reconstitution. Prescribing Information   

Patient Handout: Your Job Your Rights (PDF)  Important information for your patients. This updated four-panel brochure addresses the issues of discrimination based on diabetes in the workplace. It outlines the laws, personal rights, federally mandated accommodations, and how to address discrimination. Know Your Rights (English) Know Your Rights (Spanish)    

Researchers found little change in the prevalence and incidence of diabetes between 2008 and 2012, following drastic increases in both numbers between 1990 and 2008. "We are now for the first time showing that (those rates are) slowing down," said Dr. Ann Albright, who directs the Division of Diabetes Translation …

A six-year study of people with type 2 diabetes found that intensively lowering blood pressure had a long-lasting effect in preventing heart attacks, strokes and deaths. But intensive blood sugar control didn’t produce those benefits, the researchers found. For the study, investigators followed nearly 8,500 participants of a completed diabetes …